Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2024-09-20 Sale | 2024-09-24 7:41 pm | LIGAND PHARMACEUTICALS INC | LGND | Korenberg Matthew E President & COO | 16,047 | $102.35 | $1,642,359 | 93,608 (Direct) | View |
| 2024-08-22 Sale | 2024-08-26 8:15 pm | LIGAND PHARMACEUTICALS INC | LGND | Korenberg Matthew E President & COO | 18,858 | $105.34 | $1,986,420 | 49,510 (Direct) | View |
| 2024-08-09 Sale | 2024-08-13 5:21 pm | LIGAND PHARMACEUTICALS INC | LGND | Korenberg Matthew E President & COO | 18,245 | $98.5 | $1,797,133 | 68,368 (Direct) | View |
| 2024-05-13 Sale | 2024-05-15 7:34 pm | LIGAND PHARMACEUTICALS INC | LGND | Korenberg Matthew E President & Chief Operating | 17,598 | $84.99 | $1,495,740 | 86,263 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2024-09-20 Exercise | 2024-09-24 7:41 pm | N/A 2026-02-11 | LIGAND PHARMACEUTICALS INC | LGND | Korenberg Matthew E President & COO | 14,754 | $0 | 93,608 (Direct) | View |
| 2024-09-23 Exercise | 2024-09-24 7:41 pm | N/A N/A | LIGAND PHARMACEUTICALS INC | LGND | Korenberg Matthew E President & COO | 9,377 | $52.84 | 93,608 (Direct) | View |
| 2024-09-20 Exercise | 2024-09-24 7:41 pm | N/A N/A | LIGAND PHARMACEUTICALS INC | LGND | Korenberg Matthew E President & COO | 5,377 | $49.99 | 93,608 (Direct) | View |
| 2024-09-16 Tax Withholding | 2024-09-18 7:55 pm | N/A N/A | LIGAND PHARMACEUTICALS INC | LGND | Korenberg Matthew E President & COO | 3,214 | $105 | 114,348 (Direct) | View |
| 2024-09-16 Exercise | 2024-09-18 7:55 pm | N/A N/A | LIGAND PHARMACEUTICALS INC | LGND | Korenberg Matthew E President & COO | 849 | $58.49 | 114,348 (Direct) | View |
| 2024-09-16 Exercise | 2024-09-18 7:55 pm | N/A N/A | LIGAND PHARMACEUTICALS INC | LGND | Korenberg Matthew E President & COO | 914 | $55.75 | 114,348 (Direct) | View |
| 2024-09-16 Exercise | 2024-09-18 7:55 pm | N/A 2026-02-11 | LIGAND PHARMACEUTICALS INC | LGND | Korenberg Matthew E President & COO | 5,774 | $0 | 114,348 (Direct) | View |
| 2024-09-16 Exercise | 2024-09-18 7:55 pm | N/A N/A | LIGAND PHARMACEUTICALS INC | LGND | Korenberg Matthew E President & COO | 3,340 | $60.94 | 114,348 (Direct) | View |
| 2024-09-16 Exercise | 2024-09-18 7:55 pm | N/A N/A | LIGAND PHARMACEUTICALS INC | LGND | Korenberg Matthew E President & COO | 671 | $49.99 | 114,348 (Direct) | View |
| 2024-08-19 Option Award | 2024-08-21 7:52 pm | N/A N/A | LIFECORE BIOMEDICAL INC. | LFCR | Korenberg Matthew E Director | 24,554 | $0 | 24,554 (Direct) | View |
Ownership | 2024-08-21 6:27 pm | N/A N/A | LIFECORE BIOMEDICAL INC. | LFCR | Korenberg Matthew E Director | 0 | $0 | 0 (Direct) | View |
| 2024-06-28 Other | 2024-07-02 7:45 pm | N/A N/A | LIGAND PHARMACEUTICALS INC | LGND | Korenberg Matthew E President & Chief Operating | 350 | $60.71 | 86,963 (Direct) | View |
| 2024-02-27 Option Award | 2024-02-29 6:50 pm | N/A 2034-02-27 | LIGAND PHARMACEUTICALS INC | LGND | Korenberg Matthew E PRESIDENT & CHIEF OPERATING | 72,960 | $0 | 162,405 (Direct) | View |
| 2024-02-15 Tax Withholding | 2024-02-16 8:10 pm | N/A N/A | LIGAND PHARMACEUTICALS INC | LGND | Korenberg Matthew E PRESIDENT & CHIEF OPERATING | 4,778 | $74.65 | 89,445 (Direct) | View |
| 2024-01-02 Tax Withholding | 2024-01-04 4:07 pm | N/A N/A | LIGAND PHARMACEUTICALS INC | LGND | Korenberg Matthew E PRESIDENT & CHIEF OPERATING | 2,917 | $72.31 | 94,223 (Direct) | View |
| 2023-12-05 Tax Withholding | 2023-12-06 3:27 pm | N/A N/A | LIGAND PHARMACEUTICALS INC | LGND | Korenberg Matthew E PRESIDENT & CHIEF OPERATING | 1,984 | $59.61 | 97,140 (Direct) | View |
| 2023-06-30 Other | 2023-07-10 6:42 pm | N/A N/A | LIGAND PHARMACEUTICALS INC | LGND | Korenberg Matthew E PRESIDENT & CHIEF OPERATING | 376 | $56.78 | 99,500 (Direct) | View |
| 2023-02-23 Option Award | 2023-02-27 8:52 pm | N/A 2033-02-23 | LIGAND PHARMACEUTICALS INC | LGND | Korenberg Matthew E President & COO | 33,697 | $0 | 123,376 (Direct) | View |
| 2023-02-15 Tax Withholding | 2023-02-17 7:23 pm | N/A N/A | LIGAND PHARMACEUTICALS INC | LGND | Korenberg Matthew E President & COO | 2,890 | $72.98 | 89,679 (Direct) | View |
| 2022-12-28 Tax Withholding | 2022-12-30 5:00 pm | N/A N/A | LIGAND PHARMACEUTICALS INC | LGND | Korenberg Matthew E President & COO | 3,859 | $66.29 | 92,569 (Direct) | View |
| 2022-12-22 Option Award | 2022-12-27 6:34 pm | N/A 2032-12-22 | LIGAND PHARMACEUTICALS INC | LGND | Korenberg Matthew E President & COO | 25,967 | $0 | 25,967 (Direct) | View |
| 2022-12-13 Option Award | 2022-12-15 6:17 pm | N/A 2032-12-13 | LIGAND PHARMACEUTICALS INC | LGND | Korenberg Matthew E President & COO | 44,000 | $0 | 126,428 (Direct) | View |
| 2022-11-30 Tax Withholding | 2022-12-01 9:42 pm | N/A N/A | LIGAND PHARMACEUTICALS INC | LGND | Korenberg Matthew E President & COO | 3,593 | $72.9 | 82,428 (Direct) | View |
| 2022-11-01 Option Award | 2022-11-03 9:10 pm | N/A N/A | LIGAND PHARMACEUTICALS INC | LGND | Korenberg Matthew E President & COO | 27,714 | $0 | 86,021 (Direct) | View |
| 2022-07-11 Option Award | 2022-08-04 4:16 pm | N/A 2032-07-11 | Qualigen Therapeutics Inc. | QLGN | Korenberg Matthew E Director | 40,000 | $0 | 40,000 (Direct) | View |
| 2022-06-30 Other | 2022-07-06 8:00 pm | N/A N/A | LIGAND PHARMACEUTICALS INC | LGND | Korenberg Matthew E EVP,Finance & Strategy and CFO | 164 | $75.84 | 52,696 (Direct) | View |
| 2022-06-10 Option Award | 2022-06-14 5:54 pm | N/A N/A | LIGAND PHARMACEUTICALS INC | LGND | Korenberg Matthew E EVP,Finance & Strategy and CFO | 8,062 | $0 | 52,368 (Direct) | View |
| 2022-05-05 Option Award | 2022-05-09 8:10 pm | N/A 2032-05-05 | LIGAND PHARMACEUTICALS INC | LGND | Korenberg Matthew E EVP,Finance & Strategy and CFO | 30,189 | $0 | 30,189 (Direct) | View |
| 2022-02-15 Tax Withholding | 2022-02-16 8:23 pm | N/A N/A | LIGAND PHARMACEUTICALS INC | LGND | Korenberg Matthew E EVP,Finance & Strategy and CFO | 3,407 | $123.68 | 44,306 (Direct) | View |
| 2022-01-26 Option Award | 2022-01-28 8:43 pm | N/A N/A | LIGAND PHARMACEUTICALS INC | LGND | Korenberg Matthew E EVP,Finance & Strategy and CFO | 11,651 | $0 | 47,713 (Direct) | View |
| 2022-01-26 Tax Withholding | 2022-01-28 8:43 pm | N/A N/A | LIGAND PHARMACEUTICALS INC | LGND | Korenberg Matthew E EVP,Finance & Strategy and CFO | 3,628 | $113.68 | 47,713 (Direct) | View |
| 2021-06-30 Other | 2021-07-02 5:13 pm | N/A N/A | LIGAND PHARMACEUTICALS INC | LGND | Korenberg Matthew E EVP,Finance & Strategy and CFO | 247 | $85.91 | 39,937 (Direct) | View |
| 2021-02-15 Tax Withholding | 2021-02-18 6:27 pm | N/A N/A | LIGAND PHARMACEUTICALS INC | LGND | Korenberg Matthew E EVP,Finance & Strategy and CFO | 2,309 | $172.46 | 39,443 (Direct) | View |
| 2021-02-03 Option Award | 2021-02-05 5:02 pm | N/A 2031-02-03 | LIGAND PHARMACEUTICALS INC | LGND | Korenberg Matthew E EVP,Finance & Strategy and CFO | 22,410 | $0 | 53,343 (Direct) | View |
| 2021-01-25 Tax Withholding | 2021-01-27 7:03 pm | N/A N/A | LIGAND PHARMACEUTICALS INC | LGND | Korenberg Matthew E EVP,Finance & Strategy and CFO | 2,111 | $156.01 | 30,933 (Direct) | View |
| 2021-01-25 Option Award | 2021-01-27 7:03 pm | N/A N/A | LIGAND PHARMACEUTICALS INC | LGND | Korenberg Matthew E EVP,Finance & Strategy and CFO | 7,108 | $0 | 30,933 (Direct) | View |
| 2020-06-30 Other | 2020-07-01 8:05 pm | N/A N/A | LIGAND PHARMACEUTICALS INC | LGND | Korenberg Matthew E EVP,Finance & Strategy and CFO | 238 | $89.03 | 26,174 (Direct) | View |
| 2020-06-06 Option Award | 2020-06-08 9:22 pm | N/A 2030-06-06 | Qualigen Therapeutics Inc. | QLGN | Korenberg Matthew E Director | 50,000 | $0 | 50,000 (Direct) | View |
| 2020-02-13 Option Award | 2020-02-18 5:05 pm | N/A 2030-02-13 | LIGAND PHARMACEUTICALS INC | LGND | Korenberg Matthew E EVP,Finance & Strategy and CFO | 37,598 | $0 | 57,614 (Direct) | View |
| 2019-12-20 Tax Withholding | 2019-12-26 2:01 pm | N/A N/A | LIGAND PHARMACEUTICALS INC | LGND | Korenberg Matthew E EVP,Finance & Strategy and CFO | 2,114 | $105.87 | 20,016 (Direct) | View |
| 2019-12-20 Option Award | 2019-12-26 2:01 pm | N/A N/A | LIGAND PHARMACEUTICALS INC | LGND | Korenberg Matthew E EVP,Finance & Strategy and CFO | 4,979 | $0 | 20,016 (Direct) | View |